Fundraising Fox

Hillhouse Investment

Private equity

Singapore · Growth–Late Stage · 2 people tracked

Also known as HHLR ADVISORS, LTD. · Hillhouse Capital Management, Ltd. · Hillhouse Japan Pte. Ltd.

Find your way into Hillhouse Investment

501 people in our graph share verified history with the Hillhouse Investment team — schools, employers, funds. One of them is your warm intro.

Sara Risch, PhDunlockedknows Zhaomin Chen · together at The Ohio State University (overlapped)
×6knows the team · via The Ohio State University
knows the team · via KPMG China
×3knows the team · via The University of Hong Kong
knows the team · via Shanghai Jiao Tong University
Fox Verdict
Sign up to see your fit

Investment thesis

Hillhouse Investment describes itself as a disciplined, long-term investor grounded at the intersection of alignment, quality, and sustainability. The firm emphasizes business fundamentals, industry insights, and rigorous research to identify emerging trends and anticipate future needs. It seeks to partner with exceptional management teams and forward-thinking organizations, aiming to help traditional and high-quality businesses evolve and endure. Investing globally across healthcare, industrials, energy transition, business services, and consumer opportunities, Hillhouse prioritizes patience, tenacity, and commercial acumen to create lasting value for all stakeholders and contribute to sustainable positive change.

Source: firm website, verified Sep 1, 2026.

Stage
Growth–Late Stage
HQ
Singapore, HK
Instruments
Equity
Founded
2005
Last 12 months
2 investments
Private fund assets
$59B
Tracked investments
5

Team · 2 people

from curated

What they invest in

from 5 of 5 portfolio companies

Cleantech ×2Energy ×2Hardware ×2Medical Devices ×2AI & Machine Learning ×1Biotech ×1Deep Tech ×1FoodTech ×1

HQs:United States×2Japan×1Norway×1

Investments · 5 tracked

founders shown can be your intro path

By year:2026 · 22024 · 12023 · 25 dated

Axoftaxoft.usinApr 2026 · $55M

Axoft is developing soft, tissue-mimicking neural implants and supporting bidirectional electronics that record and stimulate brain activity through a minimally-invasive burr-hole procedure.

AI & Machine LearningDeep TechMedical DevicesCambridge, US

Paul Le Floch(Executive Officer, Director)inTianyang Ye(Director)inRachel Sha(Director)

BoardChia An Lee(Director)Benjamin Pless(Director)

Co-investorsArcherman CapitalBlindspot Ventures Management CoCastor Ventures (an Alumni Ventures Fund)Creative Destruction Lab (CDL)Safar PartnersThe Engine Ventures+2 more

Hystarhystar.orgin𝕏Jan 2023

Hystar develops PEM electrolysers for hydrogen production, using a patented design that combines fuel cell industry technology with electrolyser technology for higher efficiency and safety.

CleantechEnergyHardware

Co-investorsAP VenturesFinindusFirdaTrustbridge Partners

Hystarhystar.comin𝕏Jan 2023

Hystar is a Norwegian cleantech company that develops and manufactures high-efficiency PEM (Proton Exchange Membrane) electrolysers, which use renewable electricity and water to produce green hydrogen.

CleantechEnergyHardwareHøvik, NO

Co-investorsFirdaMOL SwitchAP VenturesFinindusNysnø Climate InvestmentsORLEN VC+1 more

Third Arc Biothirdarcbio.cominFeb 2026

Third Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering.

BiotechMedical DevicesLower Gwynedd, US

Joseph Erhardt(Executive Officer)inPeter Lebowitz(Executive Officer, Director)

BoardArjun Goyal(Director)inOtello Stampacchia(Director)inFrancesco Draetta(Director)in

Co-investorsAndreessen HorowitzVida Venturesabrdn plcBiotechnology Value FundForesite CapitalOmega Funds+1 more

株式会社ダイニーdinii.jpSep 2024

Dinii (株式会社ダイニー) uses technology to support Japan's restaurant and food-service industry, aiming to become essential infrastructure for both restaurant operators and consumers.

FoodTechRetail TechSaaSTokyo, JP

Mao Yamada(Founder)in

Co-investorsBessemer Venture PartnersCoral CapitalGlobis Capital PartnersEclecticFlight Deck Capital

Portfolio news

latest coverage across their companies

Public market activity · per SEC filings

what is this? ⓘ
Cytek Biosciences, Inc.SC 13G

Disclosed stake · filed Nov 2024

view filing ↗
Sagimet Biosciences Inc.SC 13G/A

Disclosed stake · filed Nov 2024

view filing ↗
Hesai GroupSC 13G/A

Disclosed stake · filed Mar 2024

view filing ↗
Legend Biotech CorpSC 13G/A

Disclosed stake · filed Feb 2024

view filing ↗
Gossamer Bio, Inc.SC 13G/A

Disclosed stake · filed Feb 2024

view filing ↗
China Jo-Jo Drugstores Holdings, Inc.SC 13D/A

Disclosed stake · filed Feb 2023

view filing ↗
TScan Therapeutics, Inc.SC 13G/A

Disclosed stake · filed Feb 2023

view filing ↗
SC 13G/A filingSC 13G/A

Disclosed stake · filed Feb 2022

view filing ↗
SC 13G filingSC 13G

Disclosed stake · filed Feb 2022

view filing ↗
SC 13G filingSC 13G

Disclosed stake · filed Feb 2022

view filing ↗
SC 13D/A filingSC 13D/A

Disclosed stake · filed Jul 2021

view filing ↗
SC 13G filingSC 13G

Disclosed stake · filed Jul 2021

view filing ↗

16 insider ownership filings (Forms 3/4/5)

at ArriVent BioPharma, Inc. (AVBP), BeiGene, Ltd. (BGNE), ArriVent Biopharma, Inc. (AVBP)

Files 13F institutional holdings reports · latest Aug 2019

From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.

Frequently asked questions

What stage does Hillhouse Investment invest at?
Hillhouse Investment invests at the Growth, Late Stage stages.
What sectors does Hillhouse Investment focus on?
Hillhouse Investment focuses on Advanced Manufacturing, Climate Tech, Consumer, Energy, Enterprise Software, Healthtech, Sector Agnostic.
Where is Hillhouse Investment located?
Hillhouse Investment is headquartered in Singapore, HK.

Similar investors

Featured in lists